Pubblicazioni

Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome using treosulfan based compared to other reduced-intensity or myeloablative conditioning regimens. A report of the chronic malignancies working party of the EBMT

2021 - BRITISH JOURNAL OF HAEMATOLOGY

Shimoni, A; Robin, M; Iacobelli, S; Beelen, D; Mufti, Gj; Ciceri, F; Bethge, W; Volin, L; Blaise, D; Ganser, A; Luft, T; Chevallier, P; Schwerdtfeger, R; Koster, L; de Witte, T; Kroger, N; Nagler, A; Yakoub-Agha, I

Gonadal function after busulfan compared with treosulfan in children and adolescents undergoing allogeneic hematopoietic stem cell transplant

2019 - BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Faraci, M.; Diesch, T.; Labopin, M.; Dalissier, A.; Lankester, A.; Gennery, A.; Sundin, M.; Uckan-Cetinkaya, D.; Bierings, M.; Peters, A. M. J.; Garwer, M.; Schulz, A.; Michel, G.; Giorgiani, G.; Gruhn, B.; Locatelli, F.; Giardino, S.; Uyttebroeck, A.; Rialland, F.; Itala-Remes, M.; Dreger, P.; Shaw, P. J.; Bordon, V.; Schlegel, P. G.; Mellgren, K.; Moraleda, J. M.; Patrick, K.; Schneider, P.; Jubert, C.; Lawitschka, A.; Salooja, N.; Basak, G. W.; Corbacioglu, S.; Duarte, R.; Bader, P.